Top Institutions in Ophthalmology - Retinal Gene Therapy
Leading institutions in retinal gene therapy combine clinical trial leadership, translational research in ocular drug delivery, and innovation in minimally invasive suprachoroidal injection techniques, often collaborating with biotech companies developing novel gene therapies and delivery devices.
-
#1
University of Southern California (USC) Keck School of Medicine
Los Angeles, CA
USC Keck is a leader in retinal gene therapy research, with faculty like Dr. David S. Boyer pioneering suprachoroidal delivery methods and leading clinical trials such as ALTITUDE for ABBV-RGX-314.
-
#2
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear is renowned for its pioneering work in retinal diseases and gene therapy, with extensive clinical trial experience and translational research in ocular drug delivery systems.
-
#3
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked among the top ophthalmology centers globally, with a robust clinical and research program in retinal gene therapy and innovative drug delivery techniques.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a long-standing reputation for innovation in ocular gene therapy and retinal disease research, contributing to advancements in delivery methods and clinical trial design.
-
#5
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in translational ophthalmic research, including gene therapy for retinal diseases, with expertise in clinical trials and novel drug delivery systems.